(2R,6S)-4-(tert-Butoxycarbonyl)-6-(hydroxymethyl)morpholine-2-carboxylic acid, 98%, 250mg

7-Methoxy-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one, 95.0%, 1g

2,3-Difluorobenzoic Acid>98.0%(GC)(T)5g

3-(TRIFLUOROMETHYL)-1H-INDAZOLE-5-CARBOXYLIC ACID, 95.0%, 250mg

4,4-Difluoropyrrolidine-3-carboxylic acid hydrochloride, 98%, 500mg

Sodium 3,4-dihydro-2H-pyran-2-carboxylate, 95.0%, 5g

2-Mercapto-5-methylbenzimidazole100g

tert-Butyl (3-cyano-4-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-7-fluorobenzo[b]thiophen-2-yl)carbamate, 98%, 25g

2,5-Dihydroxy-1,4-benzoquinone>98.0%(HPLC)(T)25g

2-Amino-1,1,1-trifluoropropane hydrochloride, 95.0%, 25g

Oxion Inverso material sciences OX.2153-PLM with LWD plan 5x/10x/20x objectives and LWD plan apochromatic 100x objective

rel-(1R,2S,5S)-METHYL 3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXYLATE HCL, 95.0%, 250mg

(1R,3R,8aS)-1-methyl-3-phenyltetrahydro-3H-oxazolo[3,4-a]pyrazine-5,8-dione, 95.0%, 250mg